The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Polymeric anticancer drugs with pH-controlled activation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
(1996) · PubMed · Cited by 1,141
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Block copolymer micelles as vehicles for drug delivery
Kazunori, K., Glenn S., K., Masayuki, Y., Teruo, O., & Yasuhisa, S. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90172-2 · Cited by 877
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 859
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Kataoka, K., Matsumoto, T., Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., & Kwon, G. S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00133-9 · Cited by 613
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 556
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
Poly(l-glutamic acid)–anticancer drug conjugates
Li, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00045-5 · Cited by 414
Etrych, T., Jelı́nková, M., Řı́hová, B., & Ulbrich, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00281-4 · Cited by 340
Self-citationSeymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
Self-citationPolymeric drugs based on conjugates of synthetic and natural macromolecules
Ulbrich, K., Šubr, V, Strohalm, J., Plocová, D., Jelı́nková, M., & Řı́hová, B. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00141-8 · Cited by 333
Self-citationPolyester Dendritic Systems for Drug Delivery Applications: Design, Synthesis, and Characterization
Ihre, H. R., Padilla De Jesús, O. L., Szoka, & Fréchet, J. M. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010102u · Cited by 332
Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages
Yoo, H. S., Lee, E. A., & Park, T. G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00088-3 · Cited by 324
Polymer conjugates with anticancer activity
Putnam, D., & Kopeček, J. (1995) · Advances in Polymer Science · doi:10.1007/3540587888_14 · Cited by 315
Masayuki, Y., Mizue, M., Noriko, Y., Teruo, O., Yasuhisa, S., Kazunori, K., & Shohei, I. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90139-k · Cited by 290
Targeting the prostate for destruction through a vascular address
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., Ellerby, H. M., Bredesen, D. E., Pasqualini, R., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241655998 · Cited by 285
Shen, W.-C., & Ryser, H. J.-P. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91644-2 · Cited by 277
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Kohori, F., Sakai, K., Aoyagi, T., Yokoyama, M., Sakurai, Y., & Okano, T. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00023-6 · Cited by 273
Rejmanová, P., Kopeček, J., Pohl, J., Baudyš, M., & Kostka, V. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841006 · Cited by 264
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Yasugi, K., Nagasaki, Y., Kato, M., & Kataoka, K. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00028-0 · Cited by 249
Willner, D., Trail, P. A., Hofstead, S. J., King, H. D., Lasch, S. J., Braslawsky, G. R., Greenfield, R. S., Kaneko, T., & Firestone, R. A. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00024a015 · Cited by 225
Gabizon, A., Goren, D., Horowitz, A. T., Tzemach, D., Lossos, A., & Siegal, T. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00476-0 · Cited by 221
HPMA copolymers with pH-controlled release of doxorubicin
Ulbrich, K., Etrych, T., Chytil, P., Jelı́nková, M., & Řı́hová, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00348-6 · Cited by 198
Self-citationDuncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y. N., Satchi, R., & Searle, F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00328-5 · Cited by 195
Fontana, G., Licciardi, M., Mansueto, S., Schillaci, D., & Giammona, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00030-8 · Cited by 192
Verrecchia, T., Spenlehauer, G., Bazile, D. V., Murry-Brelier, A., Archimbaud, Y., & Veillard, M. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00053-b · Cited by 189
Drug-Polymer Conjugates Containing Acid-Cleavable Bonds
Kratz, F., Beyer, U., & Schutte, M. T. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i3.10 · Cited by 181
Julyan, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00124-2 · Cited by 180
Greenfield, R. S., Kaneko, T., Daues, A., Edson, M. A., Fitzgerald, K. A., Olech, L. J., Grattan, J. A., Spitalny, G. L., & Braslawsky, G. R. (1990) · PubMed · Cited by 179
Gabizon, A., Goren, D., Cohen, R., & Barenholz, Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00261-7 · Cited by 170
pH in human tumour xenografts: effect of intravenous administration of glucose
Volk, T., Jähde, E., Fortmeyer, H., Glüsenkamp, K.-H., & Rajewsky, M. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.375 · Cited by 169
Polymer Conjugates: Pharmacokinetic Considerations for Design and Development
Duncan, R., & Spreafico, F. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427040-00004 · Cited by 164
Kaneko, T., Willner, D., Monkovic, I., Knipe, J. O., Braslawsky, G. R., Greenfield, R. S., & Vyas, D. M. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00009a001 · Cited by 163
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
Shadidi, M., & Sioud, M. (2002) · The FASEB Journal · doi:10.1096/fj.02-0280fje · Cited by 156
Controlled biodegradability of polymers — a key to drug delivery systems
Kopec̆ek, J. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90062-0 · Cited by 155
Yang, H. M., & Reisfeld, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1189 · Cited by 153
Quaternized Poly(propylene imine) Dendrimers as Novel pH-Sensitive Controlled-Release Systems
Sideratou, Z., Tsiourvas, D., & Paleos, C. M. (1999) · Langmuir · doi:10.1021/la990829v · Cited by 141
Etrych, T., Chytil, P., Jelínková, M., et al. (2002) · Macromolecular Bioscience · doi:10.1002/1616-5195(20020101)2:1<43::aid-mabi43>3.0.co;2-8 · Cited by 136
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels
Hallahan, D. E., Geng, L., Qu, S., Scarfone, C., Giorgio, T. D., Donnelly, E. F., Gao, X., & Clanton, J. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00238-6 · Cited by 134
PDEPT: polymer-directed enzyme prodrug therapy
Satchi, R., Connors, T. A., & Duncan, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2026 · Cited by 132
Laguzza, B. C., Nichols, C. L., Briggs, S., et al. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00123a007 · Cited by 128
Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs
Takakura, Y., & Hashida, M. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00131-c · Cited by 122
Tomlinson, R. D., Klee, M., Garrett, S., Heller, J., Duncan, R., & Brocchini, S. (2001) · Macromolecules · doi:10.1021/ma0108867 · Cited by 118
The crucial role of spacer groups in macromolecular prodrug design
Soyez, H., Schacht, E. H., & Vanderkerken, S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00400-0 · Cited by 107
Řı́hová, B., Etrych, T., Pechar, M., Jelínková, M., Šťastný, M., Hovorka, O., Kovář, M., & Ulbrich, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00320-0 · Cited by 106
Self-citationDesign strategies to improve soluble macromolecular delivery constructs
Christie, R. J., & Grainger, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00229-6 · Cited by 103
Design of novel bioconjugates for targeted drug delivery
Lu, Z., Shiah, J.-G., Sakuma, S., Kopečková, P., & Kopec̆ek, J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00495-3 · Cited by 103
Polymeric drugs based on conjugates of synthetic and natural macromolecules.
Řı́hová, B., Jelínková, M., Strohalm, J., Šubr, V., Plocová, D., Hovorka, O., Novák, M., Plundrová, D., Germano, Y., & Ulbrich, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00140-6 · Cited by 95
Self-citationHan, S. K., Na, K., & Bae, Y. H. (2003) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(02)00389-8 · Cited by 91
Drug targeting to specific vascular sites
Ruoslahti, E. I. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02501-1 · Cited by 89
Monoclonal antibody drug conjugates in the treatment of cancer
Trail, P. A., & Bianchi, A. B. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00012-6 · Cited by 88
Wirth, M., Fuchs, A., Wolf, M., Ertl, B., & Gabor, F. (1998) · Pharmaceutical Research · doi:10.1023/a:1011926026653 · Cited by 82
Braslawsky, G. R., Kadow, K. F., Knipe, J. O., et al. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741596 · Cited by 82
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K., Etrych, T., Chytil, P., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.02.001 · Cited by 82
Self-citationThomson, A. H., Vasey, P. A., Murray, L. S., Cassidy, J., Fraier, D., Frigerio, E., & Twelves, C. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690657 · Cited by 81
Synthesis and in Vitro Efficacy of Transferrin Conjugates of the Anticancer Drug Chlorambucil
Beyer, U., Roth, T. F., Schumacher, P. M., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9704661 · Cited by 80
Dillman, R. O., Johnson, D. E., Shawler, D. L., & Koziol, J. (1988) · PubMed · Cited by 77
Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1)
Duncan, R., Coatsworth, J. K., & Burtles, S. S. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801700204 · Cited by 76
Progress in immunoconjugate cancer therapeutics
Payne, G. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00057-6 · Cited by 76
Lectin-mediated drug delivery: binding and uptake of BSA-WGA conjugates using the Caco-2 model
Gabor, F., Schwarzbauer, A., & Wirth, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00049-2 · Cited by 74
Hopewell, J. W., Duncan, R., Wilding, D., & Chakrabarti, K. (2001) · Human & Experimental Toxicology · doi:10.1191/096032701682693017 · Cited by 72
Differences in the intracellular fate of free and polymer-bound doxorubicin
Hovorka, O., Šťastný, M., Etrych, T., Šubr, V., Strohalm, J., Ulbrich, K., & Říhová, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00016-0 · Cited by 72
Self-citationKovář, M., Strohalm, J., Etrych, T., Ulbrich, K., & Řı́hová, B. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010063m · Cited by 70
Self-citationAntibody conjugates with morpholinodoxorubicin and acid cleavable linkers
Mueller, B. M., Wrasidlo, W., & Reisfeld, R. A. (1990) · Bioconjugate Chemistry · doi:10.1021/bc00005a005 · Cited by 69
Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature
Hallahan, D. E., Geng, L., Cmelak, A. J., Chakravarthy, A. B., Martin, W., Scarfone, C., & González, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00335-2 · Cited by 61
Trail, P. A., Willner, D., Knipe, J. O., et al. (1997) · PubMed · Cited by 56
New protein crosslinking reagents that are cleaved by mild acid
Srinivasachar, K., & Neville, D. M. (1989) · Biochemistry · doi:10.1021/bi00432a023 · Cited by 54
Carrión, C., Domingo, J. C., & de Madariaga, M. A. (2001) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(01)00178-5 · Cited by 54
Synthesis and In vitro efficacy of acid-Sensitive poly(ethylene glycol) paclitaxel conjugates
Rodrigues, P. C. A., Scheuermann, K., Stockmar, C., Maier, G., Fiebig, H., Unger, C., Mülhaupt, R., & Kratz, F. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01002-8 · Cited by 52
Choi, W.-M., Kopečková, P., Minko, T., et al. (1999) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159901400601 · Cited by 49
Lectin-mediated drug delivery: influence of mucin on cytoadhesion of plant lectins in vitro
Wirth, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00538-7 · Cited by 46
Tang, A., Kopečková, P., & Kopec̆ek, J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022639701388 · Cited by 45
Kratz, F., Beyer, U., Schumacher, P., Krüger, M., Zahn, H., Roth, T. F., Fiebig, H., & Unger, C. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)00069-3 · Cited by 44
Poly(carboxylic acid) polymers as carriers for anthracyclines
Zunino, F., Pratesi, G., & Micheloni, A. (1989) · Journal of Controlled Release · doi:10.1016/0168-3659(89)90018-7 · Cited by 42
Patel, V. F., Hardin, J. N., Mastro, J. M., et al. (1996) · Bioconjugate Chemistry · doi:10.1021/bc960038u · Cited by 38
Wirth, M., Kneuer, C., Lehr, C., & Gabor, F. (2002) · Journal of drug targeting · doi:10.1080/1061186021000038300 · Cited by 35
New derivatives of polyglutamic acid as drug carrier systems
Hoste, K., Schacht, E. H., & Seymour, L. W. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00142-x · Cited by 34
Searle, F., Gac-Breton, S., Keane, R., Dimitrijević, S., Brocchini, S., Sausville, E. A., & Duncan, R. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001544 · Cited by 33
Synthesis and in vitro stability of macromolecular prodrugs of norfloxacin
Coessens, V., Schacht, E. H., & Domurado, D. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01655-6 · Cited by 32
Akamatsu, K., Yamasaki, Y., Nishikawa, M., Takakura, Y., & Hashida, M. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35028-1 · Cited by 27
Conjugate of Doxorubicin with a Thermosensitive Polymer Drug Carrier
Chtryt, V., & Ulbrich, K. (2001) · Journal of Bioactive and Compatible Polymers · doi:10.1106/fdum-1lxe-wgj9-byvw · Cited by 27
Self-citationAkamatsu, K., Yamasaki, Y., Nishikawa, M., Takakura, Y., & Hashida, M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00799-7 · Cited by 27
Biodegradable nanospheres for local drug delivery to prevent restenosis after balloon angioplasty
Wonder, M., Buttafoco, L., Wiertz, R. W. F., Zweers-Peter, K., Dijkstra, P. J., Poot, A. A., Rutten, W., Marani, E., & Feijén, J. (2000) · University of Twente Research Information · Cited by 17
Zhu, Z., Kralovec, J. A., GHOSE, T., & Mammen, M. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01519900 · Cited by 15
Stearne, L. E. T., Schiffelers, R. M., Smouter, E., Bakker‐Woudenberg, I. A. J. M., & Gyssens, I. C. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00460-6 · Cited by 13
Brich, Z., Ravel, S. J., Kissel, T., Fritsch, J., & Schöffmann, A. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90080-b · Cited by 12
Tritylated oncolytics as prodrugs
Patel, V. F., Hardin, J. N., Grindey, G. B., et al. (1995) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(95)00063-y · Cited by 8
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1738 · Cited by 1,285
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Sun, Q., Zhou, Z., Qiu, N., & Shen, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606628 · Cited by 1,058
Glutathione-Mediated Delivery and Release Using Monolayer Protected Nanoparticle Carriers
Hong, R., Han, G., Fernández, J. M., Kim, B.-J., Forbes, N. S., & Rotello, V. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056726i · Cited by 817
Metadata
- Authors
- Ulbrich, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-04-23
- Volume
- 56
- Issue
- 7
- Pages
- 1023-1050
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2036570425
- Cited by
- 494
- References
- 100
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.